Xizi Dai

581 total citations
8 papers, 389 citations indexed

About

Xizi Dai is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Xizi Dai has authored 8 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Xizi Dai's work include Pancreatic and Hepatic Oncology Research (7 papers), Pancreatitis Pathology and Treatment (3 papers) and Cancer-related Molecular Pathways (2 papers). Xizi Dai is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Pancreatitis Pathology and Treatment (3 papers) and Cancer-related Molecular Pathways (2 papers). Xizi Dai collaborates with scholars based in United States. Xizi Dai's co-authors include Nagaraj S. Nagathihalli, Nipun B. Merchant, Michael N. VanSaun, Jason Castellanos, Austin R. Dosch, Fanuel Messaggio, Siddharth Mehra, Purushottam Lamichhane, Yanhua Xiong and Iago De Castro Silva and has published in prestigious journals such as Gastroenterology, Cancer Research and American Journal of Physiology-Gastrointestinal and Liver Physiology.

In The Last Decade

Xizi Dai

8 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xizi Dai United States	8	289	147	122	67	44	8	389
Yigang Qian China	8	295 1.0×	130 0.9×	249 2.0×	86 1.3×	41 0.9×	12	479
Charles Pallangyo Germany	4	199 0.7×	126 0.9×	84 0.7×	102 1.5×	24 0.5×	5	290
Benno Traub Germany	9	156 0.5×	126 0.9×	86 0.7×	54 0.8×	48 1.1×	20	307
Shaoyan Cheng China	9	219 0.8×	148 1.0×	225 1.8×	77 1.1×	66 1.5×	10	434
Manu Prasad Israel	12	146 0.5×	183 1.2×	54 0.4×	83 1.2×	59 1.3×	27	359
H Takeyama Japan	5	233 0.8×	183 1.2×	92 0.8×	111 1.7×	29 0.7×	13	410
Nicole Liscia Italy	7	226 0.8×	131 0.9×	73 0.6×	104 1.6×	112 2.5×	29	374
Denis I. Trufa Germany	13	174 0.6×	155 1.1×	190 1.6×	76 1.1×	63 1.4×	21	421
Jong‐Ho Lee South Korea	8	120 0.4×	203 1.4×	103 0.8×	118 1.8×	40 0.9×	12	380
Zhaoying Yao China	6	162 0.6×	192 1.3×	156 1.3×	85 1.3×	40 0.9×	7	378

Countries citing papers authored by Xizi Dai

Since Specialization

Citations

This map shows the geographic impact of Xizi Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xizi Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xizi Dai more than expected).

Fields of papers citing papers by Xizi Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xizi Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xizi Dai. The network helps show where Xizi Dai may publish in the future.

Co-authorship network of co-authors of Xizi Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xizi Dai. A scholar is included among the top collaborators of Xizi Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xizi Dai. Xizi Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Datta, Jashodeep, Xizi Dai, Anna Bianchi, et al.. (2022). Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer. Gastroenterology. 163(6). 1593–1612. 108 indexed citations

Mehra, Siddharth, Supriya Srinivasan, Samara P. Singh, et al.. (2022). Urolithin A attenuates severity of chronic pancreatitis associated with continued alcohol intake by inhibiting PI3K/AKT/mTOR signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology. 323(4). G375–G386. 12 indexed citations

Dosch, Austin R., Samara P. Singh, Xizi Dai, et al.. (2021). Targeting Tumor–Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer. Molecular Cancer Therapeutics. 20(11). 2280–2290. 33 indexed citations

Willobee, Brent A., Austin R. Dosch, Jason Castellanos, et al.. (2021). Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 20(7). 1246–1256. 25 indexed citations

Dosch, Austin R., Xizi Dai, Michelle L. Reyzer, et al.. (2020). Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic Cancer. Molecular Cancer Research. 18(4). 623–631. 40 indexed citations

Dosch, Austin R., Xizi Dai, Chanjuan Shi, et al.. (2019). Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells. Oncotarget. 10(10). 1056–1069. 12 indexed citations

Nagathihalli, Nagaraj S., Jason Castellanos, Purushottam Lamichhane, et al.. (2018). Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer. Cancer Research. 78(21). 6235–6246. 68 indexed citations

Nagathihalli, Nagaraj S., Jason Castellanos, Michael N. VanSaun, et al.. (2016). Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells. Oncotarget. 7(40). 65982–65992. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact